Latest Breaking News On - பயன்படுத்தப்பட்டது மருந்து கண்டுபிடிப்பு - Page 3 : comparemela.com

Press release content from Accesswire. The AP news staff was not involved in its creation. XPhyto Announces Psychedelic Pharmaceutical Production Agreement February 3, 2021 GMT VANCOUVER, BC / ACCESSWIRE / February 3, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce that XPhyto Laboratories Inc. (“XPhyto Labs”), its wholly owned Alberta subsidiary, has signed an agreement (the “Agreement”) with Applied Pharmaceutical Innovation (“Applied”) for the synthesis of pharmaceutical grade psychedelic compounds and the parallel development of the standard operating procedures necessary to obtain regulatory approval for the respective commercial production process. The industrial-scale production of standardized active pharmaceutical ingredients is an important part of XPhyto’s psychedelic pharmaceutical program as the Company anticipates a shortage of large-scale supply of certain approved and standar

United statesBritish columbiaJulia hofmannHugh rogersKnox hendersonAndreas jungferMc servicesXphyto therapeutics corpUniversity of albertaXphyto laboratories incApplied pharmaceutical innovationDealing agreementNorth americaTherapeutics corpMarket regulatorஒன்றுபட்டது மாநிலங்களில்